New drugs that neutralize so-called 'heat shock' proteins are nearing market approval to treat cancer. Yet, beyond their tumor-fighting potential, these same drugs have also shown promise against parasites, inflammatory diseases and even neurodegenerative disorders. Elie Dolgin and Alison Motluk talk with the scientists hoping these drugs will turn up the temperature on a broad range of disease targets.
References
Banumathy, G., Singh, V., Pavithra, S.R. & Tatu, U. J. Biol. Chem. 278, 18336–18345 (2003).
Kumar, R., Pavithra, S.R. & Tatu, U. J. Biosci. 32, 531–536 (2007).
Pallavi, R. et al. J. Biol. Chem. 285, 37964–37975 (2010).
Geller, R., Vignuzzi, M., Andino, R. & Frydman, J. Genes Dev. 21, 195–205 (2007).
Cowen, L.E. & Lindquist, S. Science 309, 2185–2189 (2005).
Cowen, L.E. et al. Proc. Natl. Acad. Sci. USA 106, 2818–2823 (2009).
Devaney, E., O'Neill, K., Harnett, W., Whitesell, L. & Kinnaird, J.H. Int. J. Parasitol. 35, 627–636 (2005).
Taldone, T. et al. PLoS Negl. Trop. Dis. 4, e714 (2010).
Shahinas, D., Liang, M., Datti, A. & Pillai, D.R. J. Med. Chem. 53, 3552–3557 (2010).
Dello Russo, C. et al. J. Neurochem. 99, 1351–1362 (2006).
Yun, T.J. et al. J. Immunol. 186, 563–575 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E., Motluk, A. Heat shock and awe. Nat Med 17, 646–649 (2011). https://doi.org/10.1038/nm0611-646
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0611-646
- Springer Nature America, Inc.
This article is cited by
-
Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs
Nature Reviews Microbiology (2012)